Delivery Order SPE2DB20D2104-SPE2DB25FNAMG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $5,560.68. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively made. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $2,311.42 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) on November 14, 2025, with completion scheduled for November 17, 2025. This competitively awarded, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under a larger procurement vehicle. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Carvedilol ER 20 mg capsules in quantities of 30 units. This non-set-aside, competitively awarded contract carries a ceiling value of $1,436.98 with firm fixed pricing and is scheduled for completion by September 4, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,963.74 on June 3, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages). This competitively awarded, firm fixed-price contract is non-set-aside and carries an ultimate completion date of June 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) valued at $3,734.34. This is a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Carvedilol ER 20 mg capsules in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $5,857.63 and an ultimate completion date of December 9, 2025. The contract carries no set-aside designation and represents a competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $2,756.79 and an ultimate completion date of July 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing contract vehicle. The performance location is the company's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order valued at $3,159.65 to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a firm fixed price ceiling value of $2,539.62 and ultimate completion date of December 1, 2025. This is a non-set-aside competitive award classified as a delivery order under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count packages) with a ceiling value of $2,217.14. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 12, 2025. This delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNAMGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $3,827.40. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This contract delivery exemplifies AmerisourceBergen's critical role as a federal pharmaceutical supplier supporting military and veteran healthcare systems. The company maintains a comprehensive portfolio of medications and medical supplies distributed through the DLA Medical Supply Chain, fulfilling federal procurement requirements across multiple therapeutic domains through competitively awarded contracts. The SPE2DX IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply brand-name and generic drugs, vaccines, and specialized medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/15/25 |